Exogenous basic fibroblast growth factor increases collateral blood flow in female rats with femoral artery occlusion

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 1, 2006, Pages 146-154

  Allen, Laura A ^a   Terjung, Ronald L ^b,c,d   Yang, H T ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Arteriogenesis; Collateral vessels; Microspheres; Skeletal muscle; Treadmill running

Indexed keywords

CERIUM 141; FIBROBLAST GROWTH FACTOR 2; MICROSPHERE; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; N(G) NITROARGININE METHYL ESTER; PLACEBO; STRONTIUM 85;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; BLOOD PRESSURE; COLLATERAL CIRCULATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; HEART RATE; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; COLLATERAL CIRCULATION; FEMALE; FEMORAL ARTERY; FIBROBLAST GROWTH FACTOR 2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646710990     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000199145.54220.58     Document Type: Article

References (47)

1. O'Donnell TFJ. Arterial diagnosis and management of acute thrombosis of the lower extremity. Can J Surg. 1993;36:349-353.
2. Dormandy JA, Thomas PRS. What is the natural history of a critically ischemic patient with and without his leg? In Limb Salvage and Amputation for Vascular Disease. WB Saunders, Philadelphia. 1988:11-26.
3. Albers M, Fratezi AC, De Luccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg. 1992;16:54-59.
4. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
5. Chleboun JO, Martins RN, Mitchell CA, et al. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Commun. 1992;185:510-516.
6. Chleboun JO, Martins RN. The development and enhancement of the collateral circulation in an animal model of lower limb ischaemia. Austr New Zeal Surg. 1994;64:202-207.
7. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92:II365-II371.
8. Yang HT, Deschenes MR, Ogilvie RW, et al. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res. 1996;79:62-69.
9. Yang HT, Ogilvie RW, Terjung RL. Exercise training enhances basic fibroblast growth factor-induced collateral blood flow. Am J Physiol Heart Circ Physiol. 1998;274:H2053-H2061.
10. Yang HT, Feng Y, Allen LA, et al. Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol. 2000;278:H1966-H1973.
11. Yang HT, Yan Z, Abraham JA, et al. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol. 2001;280:H1097-H1104.
12. Bauters C, Asahara T, Zheng LP, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21:314-325.
13. Takeshita S, Pu LQ, Stein LA, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation. 1994;90:II228-II234.
14. Takeshita S, Rossow ST, Kearney M, et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 1995;147:1649-1660.
15. Takeshita S, Weir L, Chen D, et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun. 1996;227:628-635.
16. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-583.
17. Martins RN, Chleboun JO, Sellers P, et al. The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors. 1994;10:299-306.
18. Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9:604-613.
19. Yang HT, Feng Y. bFGF increases collateral blood flow in aged rats with femoral artery ligation. Am J Physiol Heart Circ Physiol. 2000;278:85-93.
20. Srivastava S, Terjung RL, Yang HT. Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2003;285:H1190-H1197.
21. House SL, Bolte C, Zhou M, et al. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation. 2003;108:3140-3148.
22. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
23. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994;94:623-630.
24. Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res. 2002;90:966-973.
25. Yang HT, Dinn RF, Terjung RL. Training increases muscle blood flow in rats with peripheral arterial insufficiency. J Appl Physiol. 1990;69:1353-1359.
26. Yang HT, Terjung RL. Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow. J Appl Physiol. 1993;75:452-457.
27. Wagner JD, Kaplan JR, Burkman RT. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications. Obstetr Gynecol Clin N Am. 2002;29:475-493.
28. Rusnati M, Casarotti G, Pecorelli S, et al. Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium. Gynecol Oncol. 1993;48:83-93.
29. Selzman CH, Gaynor JS, Turner AS, et al. Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation. 1998;98:2049-2054.
30. Lamping KG, Christensen LP, Tomanek RJ. Estrogen therapy induces collateral and microvascular remodeling. Am J Physiol Heart Circ Physiol. 2003;285:H2039-H2044.
31. Kyriakides ZS, Petinakis P, Kaklamanis L, et al. Gender does not influence angiogenesis and arteriogenesis in a rabbit model of chronic hind limb ischemia. Int J Cardiol. 2003;92:83-91.
32. Dudley GA, Abraham WM, Terjung RL. Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle. J Appl Physiol. 1982;53:844-850.
33. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
34. Buckberg GD, Luck JC, Hoffman JI, et al. Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol. 1971;31:598-604.
35. Greene EC. Anatomy of the Rat. New York: Hafner Publishing Company; 1963.
36. Steel RGD, Torrie JH. Principal and Procedures of Statistics. New York: McGraw Hill; 1960.
37. Prior BM, Lloyd PG, Ren J, et al. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol. 2004;287:H2434-H2447.
38. Whalen GF, Shing Y, Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors. 1989;1:157-164.
39. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-670.
40. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-H1595.
41. Cuevas P, Carceller F, Ortega S, et al. Hypotensive activity of fibroblast growth factor. Science. 1991;254:1208-1210.
42. Babaei S, Teichert-Kuliszewska K, Monge JC, et al. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res. 1998;82:1007-1015.
43. Stavri GT, Zachary IC, Baskerville PA, et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation. 1995;92:11-14.
44. Yang HT, Li H, Prior BM, et al. VEGF receptor antagonist only partially blocks FGF-2 induced increase in collateral blood flow [abstract]. FASEB J. 2004;18:A1235.
45. Jin ZG, Ueba H, Tanimoto T, et al. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res. 2003;93:354-363.
46. Arras M, Ito WD, Scholz D, et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50.
47. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res. 1989;1:207-235.